Trinity Bio ADR (TRIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,138 | 5,167 | 3,691 | 6,578 | 25,910 |
| Receivables | 11,480 | 16,065 | 13,901 | 15,753 | 16,116 |
| Inventories | 18,828 | 19,374 | 19,933 | 22,503 | 29,123 |
| Other current assets | 456 | 518 | 1,516 | 1,834 | 1,539 |
| TOTAL | $35,902 | $41,124 | $39,041 | $46,668 | $72,688 |
| Non-Current Assets | |||||
| PPE Net | 5,302 | 4,621 | 1,892 | 5,682 | 5,918 |
| Investments And Advances | 249 | 166 | 178 | 128 | 0 |
| Intangibles | 56,987 | 51,343 | 16,270 | 35,269 | 35,981 |
| Other Non-Current Assets | 6,725 | 6,036 | 2,054 | 4,357 | 4,308 |
| TOTAL | $69,263 | $62,166 | $20,394 | $45,436 | $46,207 |
| Total Assets | $105,165 | $103,290 | $59,435 | $92,104 | $118,895 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 108,015 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 29,703 | 26,782 | 12,802 | 15,375 | 15,127 |
| Other current liabilities | 693 | 2,818 | 329 | 78 | 72 |
| TOTAL | $141,209 | $32,095 | $15,035 | $17,339 | $100,491 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 72,391 | 40,109 | 44,301 | N/A |
| Other Non-Current Liabilities | 20,431 | 18,947 | 15,068 | 15,315 | 0 |
| TOTAL | $35,938 | $106,376 | $68,349 | $76,941 | $18,723 |
| Total Liabilities | $177,147 | $138,471 | $83,384 | $94,280 | $119,214 |
| Shareholders' Equity | |||||
| Common Shares | 40 | 4,190 | 1,972 | 1,963 | 1,213 |
| Retained earnings | -116,169 | -79,117 | -48,644 | -26,695 | 12,559 |
| Other shareholders' equity | 5,347 | 1,349 | 1,104 | 1,098 | -5,278 |
| TOTAL | $-71,982 | $-35,181 | $-23,949 | $-2,176 | $-319 |
| Total Liabilities And Equity | $105,165 | $103,290 | $59,435 | $92,104 | $118,895 |